Sneijeev Ventures Pvt. Ltd. Acquires Shares in Amerise Biosciences Ltd.
Amerise Biosciences Ltd. has reported a transaction involving the acquisition of shares by Sneijeev Ventures Pvt. Ltd., acting alongside several Persons Acting in Concert (PAC). The acquisition was executed through open market transactions, resulting in a shift in the shareholding structure of the company.The acquirer, Sneijeev Ventures Pvt. Ltd., is not part of the promoter or promoter group of Amerise Biosciences Ltd. The transaction involves participants including Rushank S. Lunkad, Sneha Lunkad, Riddhi Lunkad, and Sanjeev Lunkad as Persons Acting in Concert (PAC).
Before this transaction, the acquirer held 6,153,446 shares, representing a 9.31% stake in the total share and voting capital of Amerise Biosciences Ltd. During the transaction period, the entity acquired an additional 318,285 shares, which accounted for 0.48% of the total diluted share/voting capital.
Following the completion of these open market purchases, the total holding of the acquirer stands at 5,835,161 shares, representing an 8.83% stake in the company.
The transaction details and the change in shareholding are outlined in the table below:
| Transaction Detail | Before Acquisition | Amount/Percentage Acquired | After Acquisition |
|---|---|---|---|
| Number of Shares | 6,153,446 | 318,285 | 5,835,161 |
| % of Voting Capital | 9.31% | 0.48% | 8.83% |
The total equity share capital of Amerise Biosciences Ltd. remains unchanged following the transaction. The company maintains a total issued capital of Rs. 6,60,69,000, consisting of 6,60,690 equity shares with a face value of Rs. 10 each.
Stock Price Movement
As of 10:14, Amerise Biosciences Ltd shares are holding steady at ₹0.93, showing no change in price. The stock is currently trading completely flat as it remains locked at the intraday high and low of ₹0.93.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.